• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年轻人真性红细胞增多症:对40岁之前确诊的58例病例的分析

Polycythaemia vera in young people: an analysis of 58 cases diagnosed before 40 years.

作者信息

Najean Y, Mugnier P, Dresch C, Rain J D

机构信息

Department of Nuclear Medicine and Haematology, Hôpital Saint-Louis, Paris, France.

出版信息

Br J Haematol. 1987 Nov;67(3):285-91. doi: 10.1111/j.1365-2141.1987.tb02349.x.

DOI:10.1111/j.1365-2141.1987.tb02349.x
PMID:3689694
Abstract

Over 20 years, 58 cases of PV in young people (46 meeting the full PVSG criteria, 12 with elevated red cell volume and leucocytosis or thrombocytosis, without splenomegaly) were studied and have been followed for periods of 3-24 years. These cases represent approximately 5% of the cases of PV referred to the Department of Nuclear Medicine of St Louis Hospital during this period. They differ from older patients in the initial clinical severity, the short interval between the first symptoms and the diagnosis, frequent presentation with a life-threatening complication (two cases of hepatic vein thrombosis, six thrombotic or haemorrhagic events, six splenectomies, two abortions) and a very enlarged spleen in half the cases. However, after the initial complications, the overall survival is very long (exceeding 70%, even when including the initial complications, at 15 years). The vascular accidents occur exclusively in the phlebotomized patients, the main risk factor being the poor stability of the haematocrit. Only one acute leukaemia was observed among the 14 cases treated by radioactive phosphorus and/or alkylating chemotherapy. The most frequent late complication was evolution towards myelofibrosis. This spent phase seemed to occur earlier in patients treated by phlebotomy. On the basis of this data, we would advise the following therapeutic strategy: phlebotomies, as soon as the diagnosis is established, and a systematic long-term treatment by hydroxyurea with the hope of reducing the number of vascular complications and of delaying the evolution towards the spent phase and the myelofibrosis.

摘要

在20多年间,对58例青年真性红细胞增多症患者(46例符合完整的PVSG标准,12例红细胞体积升高且白细胞增多或血小板增多,无脾肿大)进行了研究,并随访了3至24年。这些病例约占在此期间转诊至圣路易斯医院核医学科的真性红细胞增多症病例的5%。他们与老年患者在初始临床严重程度、首发症状与诊断之间的间隔时间短、常伴有危及生命的并发症(2例肝静脉血栓形成、6例血栓形成或出血事件、6例脾切除术、2例流产)以及半数病例脾脏非常肿大等方面有所不同。然而,在初始并发症之后,总体生存期很长(即使包括初始并发症,15年时超过70%)。血管意外仅发生在放血治疗的患者中,主要危险因素是血细胞比容稳定性差。在14例接受放射性磷和/或烷化化疗的患者中仅观察到1例急性白血病。最常见的晚期并发症是向骨髓纤维化演变。这种终末期似乎在接受放血治疗的患者中出现得更早。基于这些数据,我们建议采取以下治疗策略:一旦确诊即进行放血治疗,并采用羟基脲进行系统性长期治疗,以期减少血管并发症的数量,并延缓向终末期和骨髓纤维化的演变。

相似文献

1
Polycythaemia vera in young people: an analysis of 58 cases diagnosed before 40 years.年轻人真性红细胞增多症:对40岁之前确诊的58例病例的分析
Br J Haematol. 1987 Nov;67(3):285-91. doi: 10.1111/j.1365-2141.1987.tb02349.x.
2
Clinical and laboratory assessment and therapeutic problems in longstanding polycythaemia vera.
Nouv Rev Fr Hematol (1978). 1994 Apr;36(2):197-203.
3
Primary polycythaemia vera in the elderly.老年人原发性真性红细胞增多症
J Int Med Res. 1994 Mar-Apr;22(2):121-9. doi: 10.1177/030006059402200209.
4
[Diagnosis and treatment of BCR/ABL-negative myeloproliferative diseases--principles and rationale of CZEMP recommendations].[BCR/ABL 阴性骨髓增殖性疾病的诊断与治疗——CZEMP 建议的原则与依据]
Vnitr Lek. 2011 Feb;57(2):189-213.
5
The very-long-term course of polycythaemia: a complement to the previously published data of the Polycythaemia Vera Study Group.
Br J Haematol. 1994 Jan;86(1):233-5. doi: 10.1111/j.1365-2141.1994.tb03289.x.
6
Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.基于真性红细胞增多症研究组方案的真性红细胞增多症治疗建议。
Semin Hematol. 1986 Apr;23(2):132-43.
7
Indications, procedure and results for the treatment of polycythaemia vera by bleeding, pipobroman and hydroxyurea.真性红细胞增多症采用放血、马利兰和羟基脲治疗的适应症、方法及结果
Nouv Rev Fr Hematol (1978). 1993;35(5):491-8.
8
Survival in a patient with polycythaemia vera for over thirty years: implications for treatment decisions in younger patients.
Leuk Lymphoma. 1998 Dec;32(1-2):195-8. doi: 10.3109/10428199809059262.
9
Diagnosis and treatment of polycythemia vera and possible future study designs of the PVSG.真性红细胞增多症的诊断与治疗以及真性红细胞增多症研究组未来可能的研究设计
Leuk Lymphoma. 2000 Jan;36(3-4):239-53. doi: 10.3109/10428190009148845.
10
[Polyglobulia vera. Difficulties and complications of treatment by phlebotomy].
Presse Med. 1987 Feb 21;16(6):291-4.

引用本文的文献

1
Myeloproliferative neoplasms in the adolescent and young adult population: A comprehensive review of the literature.青少年和年轻成人人群中的骨髓增殖性肿瘤:文献综述。
Br J Haematol. 2024 Jul;205(1):48-60. doi: 10.1111/bjh.19557. Epub 2024 Jun 10.
2
Essential Thrombocythemia in Adolescents and Young Adults: Clinical Aspects, Treatment Options and Unmet Medical Needs.青少年和年轻成人特发性血小板增多症:临床特点、治疗选择和未满足的医学需求。
Curr Treat Options Oncol. 2023 Jul;24(7):802-820. doi: 10.1007/s11864-023-01099-8. Epub 2023 May 17.
3
Treatment outcome in a cohort of young patients with polycythemia vera.
年轻真性红细胞增多症患者队列的治疗结果。
Intern Emerg Med. 2010 Oct;5(5):411-3. doi: 10.1007/s11739-010-0429-y. Epub 2010 Jul 6.
4
New and old prognostic factors in polycythemia vera.新的和旧的预后因素在真性红细胞增多症中。
Curr Hematol Malig Rep. 2009 Jan;4(1):19-24. doi: 10.1007/s11899-009-0003-8.
5
Update on the treatment of polycythemia vera with recombinant interferon alfa or imatinib mesylate.聚乙二醇干扰素α或甲磺酸伊马替尼治疗真性红细胞增多症的最新进展。
Curr Hematol Malig Rep. 2007 Feb;2(1):43-6. doi: 10.1007/s11899-007-0006-2.
6
Clinical and hematological presentation of children and adolescents with polycythemia vera.真性红细胞增多症患儿及青少年的临床和血液学表现
Ann Hematol. 2009 Aug;88(8):713-9. doi: 10.1007/s00277-009-0758-y. Epub 2009 May 26.
7
Risk factors of long-term incidences of thrombosis, myelofibrosis and evolution into malignance in polycythemia vera: a single center experience from China.真性红细胞增多症患者发生血栓形成、骨髓纤维化及演变为恶性肿瘤的长期风险因素:来自中国的单中心经验
Int J Hematol. 2008 Dec;88(5):530-535. doi: 10.1007/s12185-008-0188-y. Epub 2008 Nov 11.
8
Treatment of polycythemia vera with recombinant interferon.
Int J Hematol. 2002 Aug;76 Suppl 2:294-5. doi: 10.1007/BF03165137.
9
Coagulation abnormalities and cerebral infarction.凝血异常与脑梗死
J Neurol Neurosurg Psychiatry. 1993 May;56(5):433-9. doi: 10.1136/jnnp.56.5.433.
10
Thrombocytosis in young people: evaluation of 57 cases diagnosed before the age of 40.年轻人血小板增多症:对57例40岁前确诊病例的评估
Blut. 1990 Apr;60(4):233-7. doi: 10.1007/BF01728790.